Big Pi Growth leads Series B investment into Numan

We are super excited to have led the $60m Series B investment in Numan!

Numan is a leading digital healthcare platform, redefining proactive healthcare in the UK focusing on diseases and conditions such as obesity and testosterone deficiency. Founded by Sokratis Papafloratos, it offers personalised, integrated end-to-end care in one digital platform including clinical guidance, medication, coaching, diagnostics and supplements, to tackle conditions that may traditionally be undertreated and help patients take control of their health.  

In a world that is becoming increasingly more health conscious and is moving towards telehealth and online treatment, Numan has treated over 650,000 patients using proprietary technology and data to build the comprehensive, preventative health platform of the future that bridges the gap between prevention and cure.

The funding will scale Numan’s platform infrastructure to serve a growing patient base and advance its AI-driven capabilities, power its expansion into female health and other conditions as well as deepen patient relationships in existing fields as well as fuel its expansion internationally. Additionally, a portion of the new funding is earmarked for expanding Numan’s operations in Greece, leveraging the country’s highly skilled tech talent. 

This marks the first investment from Big Pi Venture’s later stage/growth fund, which aims to support founders and companies in the next stage of their journey towards changing lives for the better, or transforming markets and sectors. 

We are proud to support Sokratis and the Numan team and are truly excited for what lies ahead!